<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02281604</url>
  </required_header>
  <id_info>
    <org_study_id>In-line Filter 13/14</org_study_id>
    <nct_id>NCT02281604</nct_id>
  </id_info>
  <brief_title>In-line Filters on ICU</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of 0.2/1.2 microliter in-line
      filter reduces the incidence of severe vasoplegia comparing to the 5 microliter filter.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of severe vasoplegia</measure>
    <time_frame>participants will be followed for the duration of intensive care unit stay, an expected average of 1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Organ dysfunction</measure>
    <time_frame>participants will be followed for the duration of intensive care unit stay, an expected average of 1 week</time_frame>
    <description>Severity of organdysfunction (SOFA-Score), incidence and severity of respiratory failure (Horovitz- Index), incidence and severity of acute kidney failure (RIFLE criteria), incidence and severity of delirium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>participants will be followed for the duration of intensive care unit stay, an expected average of 1 week</time_frame>
    <description>Interleukin-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU and hospital stay</measure>
    <time_frame>participants will be followed for the duration of intensive care unit/ hospital stay, an expected average of 1 or 4 week (s), respectively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 weeks</time_frame>
    <description>Incidence of preoperative myocardial infarction, stroke, pneumonia, sepsis and acute kidney failure according to routine documentation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Micropore Filters</condition>
  <arm_group>
    <arm_group_label>0.2/1.2 microliter filter</arm_group_label>
    <description>Use of 0.2/1.2 microliter filters for intravenous drug administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 mircroliter filter</arm_group_label>
    <description>Use of 5 microliter filters for intravenous drug administration</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients, which will be treated on the anaesthesiological/surgical ICU of the
        University Hospital Frankfurt between 2013 - 2014
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients

        Exclusion Criteria:

          -  Younger than 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kai Zacharowski, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Frankfurt. Department of Anesthesiology, Intensive-Care Medicine and Pain Therapy.</affiliation>
  </overall_official>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2014</study_first_submitted>
  <study_first_submitted_qc>October 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2014</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Professor Kai Zacharowski, M.D., Ph.D., FRCA</investigator_full_name>
    <investigator_title>Prof. Dr. Dr. med.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

